FAS and ovarian neoplasm: We have now confirmed our hypothesis that T cells expressing TCR1045and a Fas-4-1BB IFP would persist better within ID8VEGF ovarian tumors, with less apoptosis and potentially enhanced T cell proliferation in situ.